With increase in the count of surgical procedures performed across the globe, there has been a significant rise in the incidence of vomiting, dizziness, nausea, and other postoperative complications. However, medical researchers and pharmaceutical firms are putting strong efforts into the development of new drugs that could help reduce these symptoms. Such promising treatments are expected to exhibit high effectiveness and a strong success rate. Launch of such drugs in the industry could help the world PONV treatment market to increase growth in the foreseeable future.
Growth in the world PONV treatment market could also see a rise on the back of increasing research and development activities for making cost-effective drugs available in the industry. Additionally, governments are providing support for development of personalized medicines and novel therapies. This could be another factor augmenting demand in the market. .
However, tedious regulatory approvals and expensive healthcare costs are forecasted to hamper market growth. Nonetheless, rising emphasis on improving quality of life and availability of high-end drug delivery technologies such as biodegradable particles and microneedle arrays are projected to create ample of market opportunities in the near term.
Request Brochure for Detailed Analysis @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2969
Antihistamines, dopamine antagonists, cholinergic antagonists, steroids, and serotonin antagonists are few of the antiemetics used for managing PONV. Dimenhydrinate and diphenhydramine are two of the antihistamines commonly used. Dopamine antagonists such as phenothiazines, benzamides, and butyrophenones could be largely employed in the market. Then there is scopolamine, a cholinergic antagonist and dexamethasone, a steroid finding application in PONV management. Serotonin antagonists, viz. palonosetron, dolasetron, granisetron, and ondansetron are also employed in PONV management.